Foodservice
Nestlé Health Science to acquire IM HealthScience
August 18, 2020
Nestlé Health Science has agreed to acquire the business of IM HealthScience with its brands of IBgard, FDgard, Fiber Choice and REMfresh for an undisclosed sum, according to a press releases.
"The IMH products offer proven and trusted solutions for dietary management of specific digestive problems as well as a separate solution for regulating sleep," Greg Behar, CEO of Nestlé Health Science, said in the press release.
IMH is the innovator of IBgard and FDgard for the dietary management of irritable bowel syndrome and functional dyspepsia), respectively. In 2017, IMH added Fiber Choice, a line of prebiotic fibers, to its product line via an acquisition. REMfresh is a continuous release-and-absorption melatonin (CRA-melatonin) supplement for sleep.
